How do I buy prescription medication?
Bovilis for Cattle
BVD » 10ml Bottle (5 Doses)
IBR Marker live » 5 Doses

  • BVD » 10ml Bottle (5 Doses) £17.99
  • BVD » 50ml Bottle (25 Doses) £88.49
  • BVD » 100ml (50 Doses) £176.99
  • IBR Marker live » 5 Doses £18.49
  • IBR Marker live » 25 Doses £91.00

Selection of 5 products from

£17.99 to £176.99

Description

Vaccines for certain respiratory diseases in cattle

Need help or advice? Contact us:

  • Landline: 01582 842096
  • Mon - Fri: 8:30am - 5:00pm
  • Sat: 9:00am - 1:00pm (Collections only)
  • Email: [email protected]

All prices include VAT where applicable.

Medication Datasheets

BVD » 10ml Bottle (5 Doses)

Bovilis BVD Suspension for injection for cattle

Qualitative and quantitative composition

Each dose of 2 ml contains:

Active substance:

Inactivated cytopathogenic bovine viral diarrhoea (BVD) virus type 1 strain C-86,

containing 50 ELISA Units (EU) and inducing at least 4.6 log2 VN units*

*Mean virus neutralizing titre obtained in the potency test

Adjuvant:

Aluminium 3+ (as Al-phosphate and Al-hydroxide): 6-9 mg

Excipients:

Methyl parahydroxybenzoate: 3 mg (preservative)

For the full list of excipients, see section " Pharmaceutical particulars".

Pharmaceutical form

Suspension for injection. Red to pink-coloured turbid suspension.

Clinical particulars

Target species:

Cattle (cows and heifers).

Indications for use:

For active immunisation of cows and heifers from eight months of age onwards to protect the foetus against transplacental infection with bovine viral diarrhoea virus.

Contra-indications:

None.

Special warnings for each target species:

Vaccinate healthy animals only.

Special precaution for use:

Special precautions for use in animals

Not applicable.

Operator warnings:

Special precautions to be taken by the person administering the veterinary medicinal product to animals

In the case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.

Adverse reactions:

In very rare cases a slight swelling may be observed for 14 days at the site of injection. Also in very rare cases transient mild pyrexia may occur. In very rare cases, hypersensitivity reactions including anaphylactic shock may occur. In the event of anaphylactic type reactions, appropriate treatment such as with antihistamine, corticosteroid or adrenaline is recommended.

The frequency of adverse reactions is defined using the following convention:

- very common (more than 1 in 10 animals treated displaying adverse reaction(s))

- common (more than 1 but less than 10 animals in 100 animals treated)

- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)

- rare (more than 1 but less than 10 animals in 10,000 animals treated)

- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

Use during pregnancy, lactation or lay:

Can be used during pregnancy.

Interactions:

Safety and efficacy data are available which demonstrate that for re-vaccination -in cattle from 15 months of age onwards (i.e. those that have previously been vaccinated separately with Bovilis BVD and Bovilis IBR Marker Live) - this vaccine can be mixed and administered with Bovilis IBR Marker Live (in Member States where this veterinary medicinal product is authorised). The product literature of Bovilis IBR Marker Live should be consulted before administration of the mixed products. The adverse effects observed after administration of one dose or an overdose of the mixed vaccines are not different from those described for the vaccines administered separately.

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the product mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

Amounts to be administered and administration route:

Before using the vaccine allow it to reach ambient temperature (15 °C – 25 °C).

Shake well before use. Use sterile syringes and needles.

Intramuscular injection. 2 ml per animal.

All cattle can be vaccinated from an age of eight months onwards.

Foetal protection can be expected if the primary immunisation has been finalised 4 weeks before start of the gestation. Animals which are vaccinated later than 4 weeks before gestation or during the early gestation will not be protected against foetal infection.

Individual vaccination

Basic immunisation

Two vaccinations with an interval of 4 weeks. The second vaccination should be given not later than 4 weeks before the start of the gestation. Revaccination

One vaccination 4 weeks before start of the next gestation.

Herd vaccination

Basic immunisation

Two vaccinations with an interval of 4 weeks. For use in cattle from eight months of age, all animals should be vaccinated.

Revaccination

One vaccination 6 months after basic vaccination with next re-vaccinations at an interval no greater than 12 months.

For revaccination, the vaccine may be used for reconstitution of Bovilis IBR Marker Live for use in cattle from 15 months of age (i.e. those that have previously been vaccinated separately with Bovilis BVD and Bovilis IBR Marker Live) and the following instructions should be used:

Bovilis IBR Marker Live Bovilis BVD 5 doses + 10 ml 10 doses + 20 ml 25 doses + 50 ml 50 doses + 100 ml A single dose (2 ml) of Bovilis BVD mixed with Bovilis IBR Marker Live is given intramuscularly. Visual appearance after reconstitution of Bovilis IBR Marker Live in Bovilis BVD: As specified for Bovilis BVD alone.

Overdose:

Reactions after a double dose are not different from those after the single dose.

Withdrawal periods:

Zero days.

Pharmacological particulars

Immunological properties

Pharmacotherapeutic group: inactivated bovine viral diarrhoea vaccine.

ATC-vet code: QI02AA01.

Bovilis BVD is an adjuvanted aqueous inactivated viral vaccine for active immunisation of cows and heifers against transplacental infection with bovine viral diarrhoea virus.

Pharmaceutical particulars

Excipients: Aluminium phosphate, Aluminium hydroxide, Methylparahydroxybenzoate, Propylene glycol, Tromethamine, Tissue culture medium, Hydrochloric acid solution or tromethamine solution, Water for injections.

Major incompatibilities:

Do not mix with any other veterinary medicinal product, except with Bovilis IBR Marker Live (for revaccination only).

Shelf-life:

Shelf life of the veterinary medicinal product as packaged for sale: 18 months.

Shelf life after first opening the immediate packaging: 10 hours.

Shelf life after mixing with Bovilis IBR Marker Live: 3 hours (at room temperature).

Special precautions for storage:

Store in a refrigerator (2 °C – 8 °C). Do not freeze.

Immediate packaging:

Vials of glass (hydrolytic type I, Ph. Eur.) or plastic (polyethylene-terephthalate, PET) closed with a rubber (halogenobutyl) stopper and an aluminium cap.

Package sizes:

Carton box containing 1 glass or plastic vial of 2 ml (1 dose)

Carton box containing 1 glass or plastic vial of 10 ml (5 doses)

Carton box containing 1 glass or plastic vial of 20 ml (10 doses)

Carton box containing 1 glass or plastic vial of 50 ml (25 doses)

Carton box containing 1 glass or plastic vial of 100 ml (50 doses)

Carton box containing 1 glass or plastic vial of 250 ml (125 doses)

Not all pack sizes may be marketed.

Disposal:

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Marketing Authorisation Holder (if different from distributor)

Intervet International B.V.

Represented by Intervet UK Ltd.

Walton Manor, Walton,

Milton Keynes,

MK7 7AJ

UK

Marketing Authorisation Number

Vm 06376/4025

Date of the first authorisation or date of renewal

25 June 1999.

Date of revision of the text

May 2017.

Any other information

Legal category

BVD » 50ml Bottle (25 Doses)

Bovilis BVD Suspension for injection for cattle

Qualitative and quantitative composition

Each dose of 2 ml contains:

Active substance:

Inactivated cytopathogenic bovine viral diarrhoea (BVD) virus type 1 strain C-86,

containing 50 ELISA Units (EU) and inducing at least 4.6 log2 VN units*

*Mean virus neutralizing titre obtained in the potency test

Adjuvant:

Aluminium 3+ (as Al-phosphate and Al-hydroxide): 6-9 mg

Excipients:

Methyl parahydroxybenzoate: 3 mg (preservative)

For the full list of excipients, see section " Pharmaceutical particulars".

Pharmaceutical form

Suspension for injection. Red to pink-coloured turbid suspension.

Clinical particulars

Target species:

Cattle (cows and heifers).

Indications for use:

For active immunisation of cows and heifers from eight months of age onwards to protect the foetus against transplacental infection with bovine viral diarrhoea virus.

Contra-indications:

None.

Special warnings for each target species:

Vaccinate healthy animals only.

Special precaution for use:

Special precautions for use in animals

Not applicable.

Operator warnings:

Special precautions to be taken by the person administering the veterinary medicinal product to animals

In the case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.

Adverse reactions:

In very rare cases a slight swelling may be observed for 14 days at the site of injection. Also in very rare cases transient mild pyrexia may occur. In very rare cases, hypersensitivity reactions including anaphylactic shock may occur. In the event of anaphylactic type reactions, appropriate treatment such as with antihistamine, corticosteroid or adrenaline is recommended.

The frequency of adverse reactions is defined using the following convention:

- very common (more than 1 in 10 animals treated displaying adverse reaction(s))

- common (more than 1 but less than 10 animals in 100 animals treated)

- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)

- rare (more than 1 but less than 10 animals in 10,000 animals treated)

- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

Use during pregnancy, lactation or lay:

Can be used during pregnancy.

Interactions:

Safety and efficacy data are available which demonstrate that for re-vaccination -in cattle from 15 months of age onwards (i.e. those that have previously been vaccinated separately with Bovilis BVD and Bovilis IBR Marker Live) - this vaccine can be mixed and administered with Bovilis IBR Marker Live (in Member States where this veterinary medicinal product is authorised). The product literature of Bovilis IBR Marker Live should be consulted before administration of the mixed products. The adverse effects observed after administration of one dose or an overdose of the mixed vaccines are not different from those described for the vaccines administered separately.

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the product mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

Amounts to be administered and administration route:

Before using the vaccine allow it to reach ambient temperature (15 °C – 25 °C).

Shake well before use. Use sterile syringes and needles.

Intramuscular injection. 2 ml per animal.

All cattle can be vaccinated from an age of eight months onwards.

Foetal protection can be expected if the primary immunisation has been finalised 4 weeks before start of the gestation. Animals which are vaccinated later than 4 weeks before gestation or during the early gestation will not be protected against foetal infection.

Individual vaccination

Basic immunisation

Two vaccinations with an interval of 4 weeks. The second vaccination should be given not later than 4 weeks before the start of the gestation. Revaccination

One vaccination 4 weeks before start of the next gestation.

Herd vaccination

Basic immunisation

Two vaccinations with an interval of 4 weeks. For use in cattle from eight months of age, all animals should be vaccinated.

Revaccination

One vaccination 6 months after basic vaccination with next re-vaccinations at an interval no greater than 12 months.

For revaccination, the vaccine may be used for reconstitution of Bovilis IBR Marker Live for use in cattle from 15 months of age (i.e. those that have previously been vaccinated separately with Bovilis BVD and Bovilis IBR Marker Live) and the following instructions should be used:

Bovilis IBR Marker Live Bovilis BVD 5 doses + 10 ml 10 doses + 20 ml 25 doses + 50 ml 50 doses + 100 ml A single dose (2 ml) of Bovilis BVD mixed with Bovilis IBR Marker Live is given intramuscularly. Visual appearance after reconstitution of Bovilis IBR Marker Live in Bovilis BVD: As specified for Bovilis BVD alone.

Overdose:

Reactions after a double dose are not different from those after the single dose.

Withdrawal periods:

Zero days.

Pharmacological particulars

Immunological properties

Pharmacotherapeutic group: inactivated bovine viral diarrhoea vaccine.

ATC-vet code: QI02AA01.

Bovilis BVD is an adjuvanted aqueous inactivated viral vaccine for active immunisation of cows and heifers against transplacental infection with bovine viral diarrhoea virus.

Pharmaceutical particulars

Excipients: Aluminium phosphate, Aluminium hydroxide, Methylparahydroxybenzoate, Propylene glycol, Tromethamine, Tissue culture medium, Hydrochloric acid solution or tromethamine solution, Water for injections.

Major incompatibilities:

Do not mix with any other veterinary medicinal product, except with Bovilis IBR Marker Live (for revaccination only).

Shelf-life:

Shelf life of the veterinary medicinal product as packaged for sale: 18 months.

Shelf life after first opening the immediate packaging: 10 hours.

Shelf life after mixing with Bovilis IBR Marker Live: 3 hours (at room temperature).

Special precautions for storage:

Store in a refrigerator (2 °C – 8 °C). Do not freeze.

Immediate packaging:

Vials of glass (hydrolytic type I, Ph. Eur.) or plastic (polyethylene-terephthalate, PET) closed with a rubber (halogenobutyl) stopper and an aluminium cap.

Package sizes:

Carton box containing 1 glass or plastic vial of 2 ml (1 dose)

Carton box containing 1 glass or plastic vial of 10 ml (5 doses)

Carton box containing 1 glass or plastic vial of 20 ml (10 doses)

Carton box containing 1 glass or plastic vial of 50 ml (25 doses)

Carton box containing 1 glass or plastic vial of 100 ml (50 doses)

Carton box containing 1 glass or plastic vial of 250 ml (125 doses)

Not all pack sizes may be marketed.

Disposal:

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Marketing Authorisation Holder (if different from distributor)

Intervet International B.V.

Represented by Intervet UK Ltd.

Walton Manor, Walton,

Milton Keynes,

MK7 7AJ

UK

Marketing Authorisation Number

Vm 06376/4025

Date of the first authorisation or date of renewal

25 June 1999.

Date of revision of the text

May 2017.

Any other information

Legal category

BVD » 100ml (50 Doses)

Bovilis BVD Suspension for injection for cattle

Qualitative and quantitative composition

Each dose of 2 ml contains:

Active substance:

Inactivated cytopathogenic bovine viral diarrhoea (BVD) virus type 1 strain C-86,

containing 50 ELISA Units (EU) and inducing at least 4.6 log2 VN units*

*Mean virus neutralizing titre obtained in the potency test

Adjuvant:

Aluminium 3+ (as Al-phosphate and Al-hydroxide): 6-9 mg

Excipients:

Methyl parahydroxybenzoate: 3 mg (preservative)

For the full list of excipients, see section " Pharmaceutical particulars".

Pharmaceutical form

Suspension for injection. Red to pink-coloured turbid suspension.

Clinical particulars

Target species:

Cattle (cows and heifers).

Indications for use:

For active immunisation of cows and heifers from eight months of age onwards to protect the foetus against transplacental infection with bovine viral diarrhoea virus.

Contra-indications:

None.

Special warnings for each target species:

Vaccinate healthy animals only.

Special precaution for use:

Special precautions for use in animals

Not applicable.

Operator warnings:

Special precautions to be taken by the person administering the veterinary medicinal product to animals

In the case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.

Adverse reactions:

In very rare cases a slight swelling may be observed for 14 days at the site of injection. Also in very rare cases transient mild pyrexia may occur. In very rare cases, hypersensitivity reactions including anaphylactic shock may occur. In the event of anaphylactic type reactions, appropriate treatment such as with antihistamine, corticosteroid or adrenaline is recommended.

The frequency of adverse reactions is defined using the following convention:

- very common (more than 1 in 10 animals treated displaying adverse reaction(s))

- common (more than 1 but less than 10 animals in 100 animals treated)

- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)

- rare (more than 1 but less than 10 animals in 10,000 animals treated)

- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

Use during pregnancy, lactation or lay:

Can be used during pregnancy.

Interactions:

Safety and efficacy data are available which demonstrate that for re-vaccination -in cattle from 15 months of age onwards (i.e. those that have previously been vaccinated separately with Bovilis BVD and Bovilis IBR Marker Live) - this vaccine can be mixed and administered with Bovilis IBR Marker Live (in Member States where this veterinary medicinal product is authorised). The product literature of Bovilis IBR Marker Live should be consulted before administration of the mixed products. The adverse effects observed after administration of one dose or an overdose of the mixed vaccines are not different from those described for the vaccines administered separately.

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the product mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

Amounts to be administered and administration route:

Before using the vaccine allow it to reach ambient temperature (15 °C – 25 °C).

Shake well before use. Use sterile syringes and needles.

Intramuscular injection. 2 ml per animal.

All cattle can be vaccinated from an age of eight months onwards.

Foetal protection can be expected if the primary immunisation has been finalised 4 weeks before start of the gestation. Animals which are vaccinated later than 4 weeks before gestation or during the early gestation will not be protected against foetal infection.

Individual vaccination

Basic immunisation

Two vaccinations with an interval of 4 weeks. The second vaccination should be given not later than 4 weeks before the start of the gestation. Revaccination

One vaccination 4 weeks before start of the next gestation.

Herd vaccination

Basic immunisation

Two vaccinations with an interval of 4 weeks. For use in cattle from eight months of age, all animals should be vaccinated.

Revaccination

One vaccination 6 months after basic vaccination with next re-vaccinations at an interval no greater than 12 months.

For revaccination, the vaccine may be used for reconstitution of Bovilis IBR Marker Live for use in cattle from 15 months of age (i.e. those that have previously been vaccinated separately with Bovilis BVD and Bovilis IBR Marker Live) and the following instructions should be used:

Bovilis IBR Marker Live Bovilis BVD 5 doses + 10 ml 10 doses + 20 ml 25 doses + 50 ml 50 doses + 100 ml A single dose (2 ml) of Bovilis BVD mixed with Bovilis IBR Marker Live is given intramuscularly. Visual appearance after reconstitution of Bovilis IBR Marker Live in Bovilis BVD: As specified for Bovilis BVD alone.

Overdose:

Reactions after a double dose are not different from those after the single dose.

Withdrawal periods:

Zero days.

Pharmacological particulars

Immunological properties

Pharmacotherapeutic group: inactivated bovine viral diarrhoea vaccine.

ATC-vet code: QI02AA01.

Bovilis BVD is an adjuvanted aqueous inactivated viral vaccine for active immunisation of cows and heifers against transplacental infection with bovine viral diarrhoea virus.

Pharmaceutical particulars

Excipients: Aluminium phosphate, Aluminium hydroxide, Methylparahydroxybenzoate, Propylene glycol, Tromethamine, Tissue culture medium, Hydrochloric acid solution or tromethamine solution, Water for injections.

Major incompatibilities:

Do not mix with any other veterinary medicinal product, except with Bovilis IBR Marker Live (for revaccination only).

Shelf-life:

Shelf life of the veterinary medicinal product as packaged for sale: 18 months.

Shelf life after first opening the immediate packaging: 10 hours.

Shelf life after mixing with Bovilis IBR Marker Live: 3 hours (at room temperature).

Special precautions for storage:

Store in a refrigerator (2 °C – 8 °C). Do not freeze.

Immediate packaging:

Vials of glass (hydrolytic type I, Ph. Eur.) or plastic (polyethylene-terephthalate, PET) closed with a rubber (halogenobutyl) stopper and an aluminium cap.

Package sizes:

Carton box containing 1 glass or plastic vial of 2 ml (1 dose)

Carton box containing 1 glass or plastic vial of 10 ml (5 doses)

Carton box containing 1 glass or plastic vial of 20 ml (10 doses)

Carton box containing 1 glass or plastic vial of 50 ml (25 doses)

Carton box containing 1 glass or plastic vial of 100 ml (50 doses)

Carton box containing 1 glass or plastic vial of 250 ml (125 doses)

Not all pack sizes may be marketed.

Disposal:

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Marketing Authorisation Holder (if different from distributor)

Intervet International B.V.

Represented by Intervet UK Ltd.

Walton Manor, Walton,

Milton Keynes,

MK7 7AJ

UK

Marketing Authorisation Number

Vm 06376/4025

Date of the first authorisation or date of renewal

25 June 1999.

Date of revision of the text

May 2017.

Any other information

Legal category

Delivery Information

How quickly do you deliver?

Under almost all products on our website is an Estimated dispatch time, check this for a delivery prediction specific to the item you are looking to purchase. These badges are updated live based on the stock levels we have and also those of our suppliers - so are usually very accurate, but cannot be guaranteed. In more general terms, we aim to dispatch all orders within 1 working day of receiving payment (and a prescription if required). If we cannot do so within 3 working days we will contact you by email.

What do you charge for delivery?

For UK delivery, we charge the following:

Order Total Weight Delivery
£0-£28.99 Under 2kg £2.99
2kg+ £4.99
£29-£38.99 Under 2kg Free
2kg+ £4.99
£39+ Under 2kg Free
2kg+ Free

Prices quoted are for delivery to all parts of mainland UK except certain Scottish postcodes (where the price is higher for items sent by courier. Delivery of food abroad (including Channel Islands, N. Ireland and other islands around the UK) is charged at a higher price and free delivery is not available. Temperature controlled products, such as Insulin, are also not always subject to the standard and/or free delivery options.

For full information on our delivery charges, including prices on heavy deliveries to Scotland and abroad, see our delivery information page.

We can deliver most items to all around the world, but prices do vary. The majority of light weight orders (less than 1.5kg) can be delivered for a flat rate of £10. For an accurate estimate of the delivery charge, please put the items you require in your basket and use the "Estimate Delivery" system on the shopping basket page (you only need to enter your country and postal/zip code) for a quick quote. For deliveries to the USA you may need to go to the checkout page and enter your full address to get a quote (as some services need your state in order to quote too). For more information on international deliveries, please see our delivery information page.

Delivery of aerosols

Due to restrictions aerosols can't be sent by Royal Mail. We appreciate your understanding.

Delivery of temperature controlled items

Some products, such as insulin and frozen food, need to be delivered in insulated packaging to prevent them from getting too warm (or too cold) during transit from us to you. Purchasing any of these items in your order will result in a £1.99 charge being added to the total to cover the high cost of the insulated packaging materials. You only pay the £1.99 once per order, regardless of how many temperature controlled items you purchase in that order.

How do I cancel or return an order?

Please call us as soon as possible if you need to amend or cancel an order on 01582 842096. If your order has been processed for dispatch we will be unable to cancel or amend the order. You will however be able to return your product for a full refund*.

To return an item, you must contact us by phone or email to arrange this BEFORE posting any product back to us. We will explain the process at this stage for you.

*For full details on returns, see our terms and conditions page.

Reviews

Q & A

There are currently no questions for Bovilis for Cattle - be the first to ask one!